[Effects of canstatin gene transfection on growth and apoptosis of lung cancer A549 cells and HUV-ECC cells]. 2005

Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R.China.

BACKGROUND Angiogenesis is essential for tumor's growth and metastasis. Canstatin, a newly found potent endogenous angiogenesis inhibitor, has drawn researcher's attention to its powerful biological activities on endothelial cells. The aim of this experiment is to explore the expression and effects of canstatin gene in lung cancer A549 cells and HUV-ECC cells. METHODS Expression vector of pCMV- Script/Canstatin was transfected into A549 and ECC cells by electroporation, and the positive clone was screened by G418. Growth characteristics of the two cell lines were compared before and after transfection. Expression of canstatin protein in supernatant was examined by SDS-PAGE assay, and cell cycles of the two cell lines were analysed by flow cytometry. RESULTS The expression of canstatin gene was found in supernatant of the transfected A549 cells and ECC cells. The apoptotic rate in the transfected ECC cells (16.04%) was significantly increased compared with that of the naked plasmid control group (0.43%) and parental cell group (2.92%) (P < 0.01). The growth of the transfected ECC cells was significantly inhibited (P < 0.01). The apoptotic rate in the transfected A549 cells (0.19%) showed no marked difference from the naked plasmid control group (0.13%) and parental cell group (0.07%) (P > 0.05). No significant difference in cell growth was found among the transfected A549 cell, naked plasmid control and parental cell groups. CONCLUSIONS The results indicate that canstatin gene can express in lung cancer A549 cell line and HUV-ECC cell line, and it can specifically inhibit proliferation of endothelial cell and induce its apoptosis.

UI MeSH Term Description Entries

Related Publications

Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
September 2009, Zhongguo fei ai za zhi = Chinese journal of lung cancer,
Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
December 2018, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
June 2002, Zhongguo fei ai za zhi = Chinese journal of lung cancer,
Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
January 2016, Molecular medicine reports,
Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
May 2007, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
August 2007, Zhongguo fei ai za zhi = Chinese journal of lung cancer,
Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
November 2016, Oncology reports,
Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
April 2014, Oncology letters,
Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
June 2006, Zhongguo fei ai za zhi = Chinese journal of lung cancer,
Weizhong Lu, and Guijun Huang, and Guisheng Qian, and Yuying Li, and Shicang Yu, and Jin Li
June 2018, Chinese journal of integrative medicine,
Copied contents to your clipboard!